| |
|
|
|
Sheraton Indianapolis City Centre, Indianapolis, IN
November 4-5, 2013
Today, biospecimen collections are used by multiple research groups for varying research aims, from basic research through clinical trials. A well-managed biobank is a critical prerequisite for high-quality biological research. The proper collection, processing, storage and tracking of biospecimens are critical components allowing researchers to better link molecular and clinical information. Thus, by necessity, biobanking is both a science and a business. Cambridge Healthtech Institute’s Fifth Annual Leaders in Biobanking: Maximizing Your Investment in Biospecimens addresses both the business and science of biobanking, bringing together biomedical and biopharmaceutical researchers, regulators, biorepository managers and practitioners to investigate the best strategies for effective use of biospecimens within today’s cutting-edge research.
|
|
|
|
|
|
|
|
Organized by:
|
|
Cambridge Healthtech Institute (CHI) |
|
|
Invited Speakers:
|
|
- Andrew M. Dahlem, Ph.D., Vice President, LRL Operations-LRL Europe, Eli Lilly and Company
- Norma J. Nowak, Ph.D., CSO and Founder, Empire Genomics LLC
- Anantha Shekhar, M.D., Ph.D., Director, Indiana Clinical and Translational Sciences Institute, Indiana University School of Medicine
- Traci Runge, Breast Cancer Survivor and Stem Cell Therapy Recipient
- Brian Chadwick, Managing Member and Consultant, LookLeft Group LLC
- Andrew Brooks, Ph.D., COO, Rutgers University Cell and DNA Repository, Associate Professor, Genetics, Rutgers University
- Amelia Warner, Pharm.D., Head, Clinical Pharmacogenomics and Clinical Specimen Management, Global Clinical Development and Regulatory Affairs, Merck
- Timothy J. Geddes, Manager, Erb Family Core Molecular Laboratory, Beaumont BioBank, William Beaumont Hospital
- Anthoula Lazaris, Associate Director, HPB Transplant and Research Unit, Surgery,
- McGill University Health Centre Research Institute
- Allison Hubel, Ph.D., Professor, Mechanical Engineering and Director, Biopreservation Core Resource, University of Minnesota
- Beatrice Knudsen, M.D., Ph.D., Medical Director, Pathology and Laboratory Medicine, Cedars-Sinai Medical Center
- Alexandra Lerch-Gaggl, Ph.D., Scientific Director, Pediatric BioBank & Analytical
- Tissue Core, Children's Research Institute and Medical College of Wisconsin
- Devon D. Kelly, Director, OHSU Knight BioLibrary, Oregon Health & Science
- University, Knight Cancer Institute
- Philip Branton, M.D., Consulting Pathologist, Biorepositories and Biospecimens Research Branch, National Cancer Institute, National Institutes of Health
- Shannon McCall, M.D., Director, Duke Biospecimen Repository and Processing Core, Pathology, Duke University School of Medicine
- Dawn E. Bowles, Ph.D., Assistant Professor, Department of Surgery, Division of Surgical Sciences and Co-Director, Duke Human Heart Repository
- Dhaval K. Shah, Ph.D., Principal Scientist, Pharmacokinetics, Dynamics and Metabolism, Groton Labs, Pfizer Inc.
- Gail H. Vance, M.D., Professor, Medical & Molecular Genetics; Professor, Pathology & Lab Medicine; Director, Division Diagnostic Genomics; Director, Indiana Familial Cancer Program, Indiana University School of Medicine
- Sherilyn Sawyer, Ph.D., Scientific Director, BWH/Harvard Cohorts Biorepository, Channing Division of Network Medicine, Brigham and Women’s Hospital
- Lynn Wetherwax, Senior Manager, Research Operations Clinical Immunology & BSM, Amgen
- Katheryn Shea, Vice President, Precision Bioservices and Past President, ISBER
- Eric M. Eastman, Ph.D., CSO, DioGenix, Inc.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
October 10, 2013
|
|
|
|
|
|
|
|
Registration:
|
|
Register Now
|
|
|
E-mail:
|
|
kwaterman@healthtech.com
|
|
|
|
|
|
|
|
|